AyurMaya Capital Management Company, LP - 27 Jun 2024 Form 3 Insider Report for ALUMIS INC. (ALMS)

Role
Director, Other*, 10%+ Owner
Signature
AyurMaya Capital Management Company, LP, By AyurMaya Capital Management Company GP, LLC, Its General Partner, By: /s/ David E. Goel, Managing Member
Issuer symbol
ALMS
Transactions as of
27 Jun 2024
Net transactions value
$0
Form type
3
Filing time
27 Jun 2024, 18:42:22 UTC
Previous filing
11 May 2023
Next filing
03 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NASDAQ Series B Redeemable Convertible Preferred Stock 27 Jun 2024 Class A Common Stock 4,278,074 See footnotes F1, F2, F3, F4
holding NASDAQ Series B-2 Redeemable Convertible Preferred Stock 27 Jun 2024 Class A Common Stock 1,141,494 See footnotes F1, F2, F3, F4
holding NASDAQ Series C Redeemable Convertible Preferred Stock 27 Jun 2024 Class A Common Stock 2,726,398 See footnotes F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of preferred stock is convertible at any time, at the holder's election, into shares of Class A Common Stock on a 4.675-to-one basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on June 20, 2024) and has no expiration date. Immediately prior to the completion of the Issuer's initial public offering of voting common stock (the "Common Stock") (the "IPO"), all shares of preferred stock will automatically convert into the number of shares in column 3.
F2 Each share of Class A Common Stock shall be reclassified into one share of Common Stock immediately prior to the completion of the IPO.
F3 The securities reported herein are held by AyurMaya Capital Management Fund, LP (the "AyurMaya Fund"). AyurMaya Capital Management Company, LP (the "Investment Manager"), a Delaware limited partnership, is the investment advisor to the AyurMaya Fund. Mr. David E. Goel ("Mr. Goel", and together with the Investment Manager, the "Reporting Persons"), serves as the managing member of AyurMaya Capital Management Company GP, LLC, the general partner of the Investment Manager.
F4 The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.

Remarks:

The Investment Manager may be deemed to be a director by deputization for purposes of Section 16 under the Securities Exchange Act of 1934 by virtue of the fact that Mr. Alan Colowick, Senior Managing Director of the Investment Manager, currently serves on the board of directors of the Issuer.